Shares of Modern Mobility Aids Inc. (MDRM) Trading Down in Today’s Session
Shares of Modern Mobility Aids Inc. (OTC: MDRM), a company focusing on the life sciences and healthcare industry, are down sharply in today’s trading.
At last check, the penny stock of MDRM was trading 20.48% lower at $0.0167, with volume up from daily average of 550,497 to 15.04 million.
Modern Mobility last Friday announced that an agreement with ACGT Corp. to combine its resources and expertise with Lumigene Technologies to develop and commercialize molecular diagnostic products.
Based in Toronto, Canada, ACGT is considered as one of the prominent Canadian providers of DNA services.
Commenting on the agreement, Antonio Domingues, president and CEO of Modern Mobility, said that the involvement of ACGT combined with the staff of Lumigene will greatly help MDRM’s efforts to bring the products to market in timely manner while reducing costs substantially.
- This newsletter has been helping traders make a killing on MDRM. Click here for a 25% discount offer.
- See today’s top stock picks and market analysis
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- Want more? Check out the message board buzz for MDRM
- See what newsletters are recommending this stock pick
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
Posted by Matt Prior
on Monday, May 7th, 2012. Filed under Internet, Technology.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Tech24.org is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
© 2013